Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RR-11a is a synthetic enzyme Legumain inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,980.00 |
Description | RR-11a is a synthetic enzyme Legumain inhibitor. |
Targets&IC50 | Legumain:31-55 nM (IC50) |
In vitro | Legumain-targeted nanoparticles coupled with RR-11a demonstrate substantial ligand-receptor affinity, thereby enabling enhanced penetration and uptake within solid tumors by tumor cells. |
In vivo | Tumor-bearing mice treated with RR-11a-coupled NPs encapsulating doxorubicin results in improved tumor selectivity and drug sensitivity, It completely inhibits tumor growth. |
Molecular Weight | 560.51 |
Formula | C24H28N6O10 |
CAS No. | 1361390-56-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RR-11a 1361390-56-8 Others RR 11a RR11a inhibitor inhibit